William Lynn
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Ophthalmology top 2%
- Ocular Diseases and Behçet’s Syndrome
- Ocular Infections and Treatments
Papers in
- Epidemiology 14
- Sepsis Diagnosis and Treatment 5
- Herpesvirus Infections and Treatments 3
- Co-authors
- Douglas T. Golenbock (3 shared papers)Jonathan B. Cohen (2 shared papers)Yuchen Liu (1 shared paper)C R Raetz (1 shared paper)N Qureshi (1 shared paper)Susan Lightman (9 shared papers)Peter McCluskey (2 shared papers)Ahmed B. Sallam (2 shared papers)
- Journals
- PLoS Medicine (3 papers)Journal of Infection (3 papers)Thorax (2 papers)Journal of the Royal Society of Medicine (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
William Lynn
40 papers receiving 970 citations
Peers
Comparison fields: 5 of 106
- Microbiology 18
- Ophthalmology 162
- Immunology 407
- Microbiology 80
- Immunology and Allergy 44
Countries citing papers authored by William Lynn
This map shows the geographic impact of William Lynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Lynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Lynn more than expected).
Fields of papers citing papers by William Lynn
This network shows the impact of papers produced by William Lynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Lynn. The network helps show where William Lynn may publish in the future.
Co-authors
The 25 scholars most cited alongside William Lynn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 209 | |
| 2 | 1991 | 135 | |
| 3 | 1993 | 107 | |
| 4 | 1995 | 102 | |
| 5 | 2012 | 69 | |
| 6 | 2014 | 46 | |
| 7 | 1998 | 44 | |
| 8 | 2006 | 40 | |
| 9 | 1988 | 32 | |
| 10 | 1995 | 24 | |
| 11 | 2001 | 21 | |
| 12 | 1989 | 18 | |
| 13 | 1995 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 1995 | 11 | |
| 16 | 1999 | 10 | |
| 17 | 1997 | 10 | |
| 18 | The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. | 1995 | 10 |
| 19 | 2003 | 8 | |
| 20 | 1995 | 8 |
About William Lynn
William Lynn is a scholar working on Epidemiology, Infectious Diseases, Ophthalmology, Immunology and Surgery, having authored 43 papers that have together received 991 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (8 papers), Immune Response and Inflammation (6 papers), Sepsis Diagnosis and Treatment (5 papers), Herpesvirus Infections and Treatments (3 papers), Infectious Diseases and Tuberculosis (3 papers), Streptococcal Infections and Treatments (2 papers), Human-Automation Interaction and Safety (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Microbiology (18 citations), Ophthalmology (162 citations), Immunology (407 citations), Microbiology (80 citations) and Immunology and Allergy (44 citations). William Lynn has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Douglas T. Golenbock, Jonathan B. Cohen, Yuchen Liu, C R Raetz, N Qureshi, Susan Lightman, Peter McCluskey, Ahmed B. Sallam, Simon Taylor and Patricio Pacheco. Their work appears in journals such as PLoS Medicine, Journal of Infection, Thorax, Journal of the Royal Society of Medicine and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.